Figures
Abstract
A total of 1844 patients with hand, foot, and mouth disease (HFMD), most of them were children of age 1–3-year-old, in Central China were hospitalized from 2011 to 2012. Among them, 422 were infected with coxsackievirus A16 (CVA16), 334 were infected with enterovirus 71 (EV71), 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Molecular epidemiology analysis revealed that EV71 and CVA16 were detected year-round, but EV71 circulated mainly in July and CVA16 circulated predominantly in November, and incidence of HFMD was reduced in January and February and increased in March. Clinical data showed that hyperglycemia and neurologic complications were significantly higher in EV71-infected patients, while upper respiratory tract infection and C-reactive protein were significantly higher in CVA16-associated patients. 124 EV71 and 80 CVA16 strains were isolated, among them 56 and 68 EV71 strains were C4a and C4b, while 25 and 55 CVA16 strains were B1a and B1b, respectively. Similarity plots and bootscan analyses based on entire genomic sequences revealed that the three C4a sub-genotype EV71 strains were recombinant with C4b sub-genotype EV71 in 2B–2C region, and the three CVA16 strains were recombinant with EV71 in 2A–2B region. Thus, CVA16 and EV71 were the major causative agents in a large HFMD outbreak in Central China. HFMD incidence was high for children among household contact and was detected year-round, but outbreak was seasonal dependent. CVA16 B1b and EV71 C4b reemerged and caused a large epidemic in China after a quiet period of many years. Moreover, EV71 and CVA16 were co-circulated during the outbreak, which may have contributed to the genomic recombination between the pathogens. It should gain more attention as there may be an upward trend in co-circulation of the two pathogens globally and the new role recombination plays in the emergence of new enterovirus variants.
Citation: Liu W, Wu S, Xiong Y, Li T, Wen Z, Yan M, et al. (2014) Co-Circulation and Genomic Recombination of Coxsackievirus A16 and Enterovirus 71 during a Large Outbreak of Hand, Foot, and Mouth Disease in Central China. PLoS ONE 9(4): e96051. https://doi.org/10.1371/journal.pone.0096051
Editor: Zhiwei Chen, The University of Hong Kong, Hong Kong
Received: November 7, 2013; Accepted: April 3, 2014; Published: April 28, 2014
Copyright: © 2014 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by research grants from Major State Basic Research Development Program (973 Program) (No. 2012CB518900; http://www.973.gov.cn/Default_3.aspx), National Natural Science Foundation of China (Nos. 31230005, 812111146, and 81171525; http://www.nsfc.gov.cn/Portal0/default152.htm), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207; http://www.chinapop.gov.cn/zhuzhan/index.shtml), National Mega Project on Major Drug Development (No. 2011ZX09401-302; http://www.chinapop.gov.cn/zhuzhan/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Hand, foot, and mouth disease (HFMD) is a common communicable disease that usually affects children, particularly those less than 5 years old [1]. Since the first case was reported in 1957 [2], HFMD has continued to spread globally and is a continuing threat to public health [3]–[10]. In the past few decades, regularly reoccurring outbreaks of HFMD have been relatively centralized in the Asia-Pacific region, including Japan [6], [11], [12], Malaysia [13]–[15], Taiwan [16]–[18], Singapore [19]–[21], Thailand [22], Korea [23], and Hong Kong [24]. Since 2008, epidemic outbreaks of HFMD in China resulted in a total of approximately 3 million cases, including approximately 1500 fatal cases [25]–[33]. Thus, HFMD has already been emerged as an imperative global hazard, not only threatening the health of the children, but also causing tremendous loss and burden to both families and society.
Surveillance study and etiologic analysis demonstrated that HFMD is most commonly caused by human enteroviruses [34]. The Enterovirus genus in the family Picornaviridae consists of 4 species: A, B, C, and D [35], [36]. EV-A species is composed of at least 16 different serotypes, including 11 coxsackievirus serotypes (CVA2, CVA3, CVA4, CVA5, CVA6, CVA7, CVA8, CVA10, CVA12, CVA14, and CVA16) and 5 enteroviruse serotypes (EV71, EV76, EV89, EV90, and EV91) [37]. It has been demonstrated that enterovirus 71 (EV71) and coxsackievirus A16 (CA16) are the principal pathogens of HFMD [38].
EV71 was first described in 1974 during an outbreak with central nervous system complications in California, USA [39], [40] and associated with many outbreaks with wide clinical manifestations [41]–[43]. Since 1997, EV71 outbreaks have gained more attention as there is an upward trend in the prevalence of EV71 globally [16], [19], [44]–[52]. In recent years, many large outbreaks of EV71-associated HFMD with high morbidity and mortality have occurred in the Asia-Pacific region [8], [15], [53]–[57]. In China, large scale EV71 outbreaks associated with acute neurological diseases were occurred in 2008 [25], [58], and since then the outbreak pattern has repeated and exacerbated each year, with increasing morbidity and mortality [27], [59]. It has been confirmed that large HFMD outbreaks with fatal neurological complications that have occurred since 2008 are mainly due to subgenotype C4 of EV71 [26], [60]–[62].
CVA16 was first isolated in South Africa in 1955 [63] and subsequently sequenced in 1994 [64]. CVA16 related to HFMD have been endemic to Southeast Asia and the Pacific region for decades [21], [65]–[69]. The illness caused by CVA16 infection is usually mild [70], but fatal cases associated with CVA16 infection have also been reported [71]–[73].
An important property of enteroviruses is their ability to undergo extensive genetic recombination, which is well known to contribute to genetic variations and evolution of the viruses. Recombination in enteroviruses was first described in 1962 [74], [75], and since then several studies have demonstrated that recombination is a significant and relatively frequent event in circulating enteroviruses and that genetic exchanges could occur both within a given serotype and between different serotypes [76]–[79]. Surveillance data indicated that EV71 and CVA16 can co-circulate during HFMD outbreaks [20], [67], [80], [81]. Such co-circulation may have contributed to the genomic recombination between EV71 and CVA16 [82], [83], which was believed to have led to the emergence of a recombinant EV71 responsible for the large HFMD outbreak in China in 2008 [58]. Complete genome analysis of prototype EV-A indicated that recombination in the nonstructural region has played a role in the evolution of some EV-A prototypes [76]. Phylogenetic analyses of several available sequences of EV71 have shown that recombination occurred between EV71 and coxsackievirus A16 in the nonstructural region [84], [85] and between different subgenotypes of EV71 viruses [86]. Previous studies have been confirmed that the large-scale HFMD outbreaks with fatal neurological complications that have occurred since 2008 are mainly due to subgenotype C4 of EV71, which was identified as a recombination virus with CVA16 in 3D region [58].
In this study, a comprehensive molecular, clinical, epidemiologic, and etiologic survey of an outbreak of HFMD occurred from 2011 to 2012 in Central China was performed. A total of 1844 patients with HFMD from 26 cities or counties in Central China were hospitalized at Wuhan Medical Treatment Center and enrolled in this study. Molecular epidemiology study revealed that among the 1844 cases, 422patients were infected with CVA16, 334 infected with EV71, 38 co-infected with EV71 and CVA16, and 35 infected with other enteroviruses. Among them, 124 EV71 strains, 80 CVA16 strains, and 9 other enterovirus strains were isolated and analyzed. A spatial-temporal surveillance showed that both EV71 and CVA16 were detected year-round, but CVA16 circulated predominantly in November and EV71 circulated mainly in July. Clinical analysis showed that neurologic complications were significantly higher in EV71-infected patients, while the proportion of upper respiratory tract infections (URTIs) and the levels of C-reactive protein (CRP) were significantly higher in CVA16-infected patients. There were no significant differences between EV71-infected group and CVA16-infected group with respect to skin and mouth rashes, bronchitis, leukocytosis, polycythemia, and the concentration of blood leukocytes, erythrocytes, or glucose. Phylogenetic analyses demonstrated that all EV71 isolates belonged to C4a and C4b, and all CVA16 isolates belonged to B1a and B1b. Interestingly, we revealed that recombinant variants of EV71 and CVA16 were identified in 6 isolates, which caused mild and severe HFMD. More importantly, we noticed that EV71 C4b was reemerged and circulated widely during this outbreak after a six-year quiescent period in China.
Results
Prevalence of human enteroviruses in a HFMD outbreak in Central China
HFMD, caused by a group of enteroviruses, is a common and rash-associated illness in children under the age of 5, but can lead to mortality in large-scale outbreaks [1]. Since first being described in California [40], there have been many reports on large HFMD outbreaks globally [3], [11], [13], [20], [41], [47], [48], [52], [55], [81]. HFMD has recently been emerged as an imperative hazard, not only threatening the health of the children, but also causing tremendous loss and burden to both families and society in China [30], [32], [67]. Thus, it is necessary to perform a comprehensive survey of HFMD.
During April 2011 to March 2012, a total of 1844 HFMD patients from 26 cities and counties in Central China were diagnosed as HFMD and hospitalized at Wuhan Medical Treatment Center. Throat swabs from each of the patients were collected and subjected to RNA extraction and RT-PCR detection for causative agents using three sets of primers (Table 1), which specifically amplify a universal sequence (EVU) commonly presented in all human enteroviruses, and the specific sequences of EV71 and CVA16, respectively, as described previously [28]. Results showed that among the 1844 HFMD patients, 422 (22.8%) were infected with CVA16, 334 (18.1%) were infected with EV71, 38 (2.1%) were co-infected with EV71 and CVA16, and 35 (1.9%) were infected with other enteroviruses. For the 829 enterovirus-positive specimens, viral isolation was performed. Among them, 124 EV71 strains, 80 CVA16 strains, and 9 other enterovirus genotypes were isolated. Thus, our results demonstrated that 45.0% HFMD patients were infected with enteroviruseses and revealed that CVA16 and EV71 were the main causative agents of this HFMD outbreak in Central China.
Monthly distributions of HFMD cases and incidence of viral infection
Seasonality in the incidence of HFMD has been reported in several studies, including a seasonal peak of HFMD was detected during summer in Japan [12], [43] and most HFMD cases were reported during autumn in Finland [87]. In Asian regions, HFMD epidemics usually were peaked in the late spring and early summer, along with a second small peak in late autumn and early winter [16], [20], [88], [89]. The seasonality of HFMD suggests that meteorological variables such as mean temperature, relative humidity and wind speed might be influential in the spread of the disease [43], [90]–[92].
In this study, monthly distribution of the total 1844 HFMD cases and the patients infected with EV71 or CVA16 was investigated, respectively. Overall, HFMD cases, EV71-infected patients, and CVA16-infected patients were observed throughout the study period from April 2011 to March 2012 (Figure 1), suggesting that HFMD became endemic year-around in this region. However, two distinct seasonal peaks of HFMD were observed during this period, the first peak occurred from April through August with the highest peak in June and the second peak occurred from September through December with the highest peak in November (Figure 1). More interestingly, distinct monthly distributions between EV71 and CVA16 were also observed in this period. EV71 was the main causative agent accounting for 74.8% (229/306) of EV71- and CVA16-positive cases during the first peak, while CVA16 was the predominant causative agent accounting for 78.7% (284/361) of EV71- and CVA16-positive cases during the second peak (Figure 1). In addition, EV71-associated and CVA16-associated cases were reduced in January and February 2012, only accounting for 6.2% (49/794) of all EV71- and CVA16-positive cases, possibly due to the cold climate during these months. However, HFMD, EV71-positive cases, and CA16-positve cases were increased in March 2012 (Figure 1). These results indicated that the outbreak of EV71- and CVA16-associated HFMD were seasonal dependent. The epidemic season of EV71-associated cases, from May to July, was significantly different from the epidemic season of CA16-associated cases, which ran from October to December (p<0.001).
During April 2011 to March 2012, a total of 1844 HFMD patients from Central China were hospitalized at Wuhan Medical Treatment Center and enrolled in this study. Throat swabs from each of the patients were collected and subjected to RNA extraction and RT-PCR detection using three sets of primers specifically amplify a universal sequence commonly presented in all human enteroviruses, and the specific sequences of EV71, and CVA16, respectively. Among them, 422 were infected with CVA16, 334 were infected with EV71, 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Monthly distribution of the 1844 patients with HFMD, including the 422 patients infected with CVA16, the 334 patients infected with EV71 (EV71), and the 38 patients co-infected with EV71 and CVA16, were described.
Age and gender distribution of HFMD cases and infection of viruses
HFMD usually affects children aged below 10 years, especially those aged below 5 years [11], [22]. In this study, age distribution analyses showed that the most HFMD cases, including EV71-infected and CA16-infected patients, were less than 5 years old (Figure 2). Young children of age 1–3 were the major affected group, with most cases in children of 1–2-year-old. These results suggested that childcare centers were not the major sites for dissemination of this disease. Notably, there was a reduced incidence of HFMD in children less than 1 year-old, presumably due to maternal antibodies and less exposure to other children. For children old than 1-year, the number of EV71-associated and CA16-associated cases decreased visibly as age increased (Figure 2).
During April 2011 to March 2012, a total of 1844 HFMD patients from Central China were hospitalized at Wuhan Medical Treatment Center and enrolled. Among them, 422 were infected with CVA16, 334 were infected with EV71, 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Age distribution of the 1844 patients with HFMD, including the 422 patients infected with CVA16, the 334 patients infected with EV71, and the 38 patients co-infected with EV71 and CVA16, were described.
Although both children and adults are at risk of infecting enteroviruses, few adult cases of HFMD have been reported. In adults, the transmission of enteroviruses within households is common; however, the manifestation of the viral infection is usually limited to mild illnesses [93]. We identified three adult cases of HFMD and showed that among these incidences, a 33-year-old male who visited the hospital in December 2011 was confirmed to be infected with EV71. These results suggested that the susceptibility of children to EV71- and CA16-associated HFMD is age-dependent and that 1–3-year-old children are the most susceptible.
We also analysis the gender distribution of HFMD cases and infection of viruses. Results showed that among the HFMD cases, 66.3% were male and 33.4% were female (Figure 3). For the EV71-associated cases, the number of male cases was twice (2.0∶1.0) the number of female cases, while for the CVA16 cases, the number of male EV71 cases is almost twice (1.7∶1.0) the number of female cases (Figure 3).
During April 2011 to March 2012, a total of 1844 HFMD patients from Central China were hospitalized at Wuhan Medical Treatment Center and enrolled. Among them, 422 were infected with CVA16, 334 were infected with EV71, 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Percentage gender distribution of the 1844 patients with HFMD, including the 422 patients infected with CVA16, the 334 patients infected with EV71, and the 38 patients co-infected with EV71 and CVA16, were described.
Clinical features and laboratory data
In most cases, enterovirus infections are generally mild, however, they have also been implicated to cause a variety of diseases, ranging from asymptomatic infection, herpangina, HFMD, to more severe diseases such as menigoencephalitis, myocarditis, and neonatal sepsis, and possibly fatal encephalitis [34], [42], [49].
We carried out a comparison of clinical and laboratory study between EV71-infected patients and CVA16-infected patients in this study. Leukocytosis, polycythemia, and hyperglycemia were defined by a leukocyte count, erythrocyte count, and blood glucose concentration >17.5×109/l, 5.50×1012/l, and 8.30 mmol/l on admission, respectively. Our results revealed that body temperature (>38°C), hyperglycemia, vomiting, and central nervous system complications, including limb shaking, lethargy, and convulsion, were significantly more frequent detected in patients with EV71 infection compared to patients with CVA16 infection (Table 2). In contrast, upper respiratory tract infections (URTIs), including pharyngitis and tonsillitis, were significantly more frequent found in CVA16-infected patients compared to EV71-infected patients. The mean serum concentrations of C-reactive protein (CRP) and the proportion of patients with CRP >4.0 mg/l were significantly higher in patients with CVA16 infection than that with EV71 infection (Table 2). We also showed that the percentage of patients with hand rash, mouth rashes, buttock rash, oral rash, were very high (mare than 90%) for both EV71-infected and CVA16-infected patients, but no significant difference between the two groups. In addition, the percentages of patients with bronchitis, leukocytosis, polycythemia, and the concentrations of blood leukocytes, erythrocytes, and glucose were low (less than 10%) for both EV71-infected and CVA16-infected patients, but no significant difference between the two groups (Table 2).
Geographical distribution of HFMD cases in Centre China
Since May 2008, China collected HFMD data in a population-wide manner focused on descriptive epidemiology, seroepidemiology, virology, pathogenesis and treatment aspects, which can be more representative for the actual HFMD epidemic [31], [60], [94]–[96]. A data quality inspection report has revealed that these results are of decent quality, especially in the eastern regions of China [97]. However, there is a need for more frequent statistical analysis of the relationship between geographical location and HFMD incidence in Centre China.
The geographical distribution of HFMD cases due to EV71 or CVA16 infection within Henan and Hubei Provinces of Centre China was investigated in this study. A total of 26 cities or counties in Hubei or Henan Province, Centre China, had confirmed as outbreaks of HFMD due to EV71 or CVA16 infection (Figure 4A). Among the 794 positive cases, Wuhan City had the largest number of EV71-positive and CVA16-positive cases (81.2%, 645/794), followed by Shangcheng County (3.5%, 28/794), Ezhou City (3.3%, 26/794), Hanchuan City (2.8%, 22/794), Xiantao City (2.0%, 16/794), Macheng City (1.9%, 15/794), and Xiaogan City (1.4%, 11/794) (Figure 4B). Our results suggested that the infection rate was highly associated with the population density in urban region.
(A) Location of Henan and Hubei Provinces in China. (B) During April 2011 to March 2012, a total of 1844 HFMD patients from Central China were hospitalized at Wuhan Medical Treatment Center and enrolled. Among them, 422 were infected with CVA16, 334 were infected with EV71, 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Geographic distribution of the 422 patients infected with CVA16, the 334 patients infected with EV71, and the 38 patients co-infected with EV71 and CVA16 within Henan and Hubei Provinces in Central China were described. 4 patients are not in the display because they lived far from Wuhan City.
More detailed analyses of the geospatial distribution within Wuhan City showed that EV71 was the predominant enterovirus in Xinzhou district (59/80, 73.8%) and Jiangxia district (10/15, 66.7%) (Figure 5A), whereas CVA16 was the predominant enterovirus in Qinshan district (32/42, 76.2%), Hongshan district (33/45, 73.3%), Dongxihu district (28/41, 68.3%), Hanyang district (77/114, 67.5%), Wuchang district (35/52, 67.3%), and Caidian district (66.7%, 8/12) (Figure 5B). Other regions, including Jiangan district, Qiaokou district, Jianghan district, and Huangpi district, had high rates of both EV71 and CVA16 infection, but no significant differences between infections of the two viruses (Figure 5A and 5B). It is not clear how geographical location influence HFMD outbreaks, and thus, there is an urgent need to investigate such relationships that could help prediction of future outbreak and evaluation of mitigation strategies.
During April 2011 to March 2012, a total of 1844 HFMD patients from Central China were hospitalized at Wuhan Medical Treatment Center and enrolled. 422 were infected with CVA16, 334 were infected with EV71, 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. (A) Geographic distribution of 295 EV71-infected patients in Wuhan City was described. (B) Geographic distribution of 388 CVA16-infected patients in Wuhan City was described.
Molecular characterization and phylogenetic analyses of EV71 and CVA16 isolates
CVA16 and EV71 are most frequently implicated in HFMD, and other serotypes, including coxsackieviruses A4–10, A24, coxsackieviruses B2–5, and echovirus 18, can also cause HFMD [38]. Based on the capsid protein (VP1) coding region, EV71 is divided into three genotypes: A, B, and C [98] and within the genotypes B and C, there are further subgenotypes, B1–B5 and C1–C5 [26], [99], [100].
To determine the sub-genotypes of the EV71 and CVA16 strains circulating in Centre China during April 2011 to March 2012, we isolated 124 different EV71 strains and 80 different CVA16 strains from the enterovirus-positive specimens enrolled in this study.
It is known EV71 strains were divided into 11 sub-genotypes (A, B1–B5, and C1–C5) based on their VP1 gene sequences. In this study, 37 EV71 strains obtained from GenBank were used as reference genotypes (Table S1 in File S1). It is also known CVA16 strains were divided into two genotypes (A and B) and three sub-genotypes (A, B1, and B2) based on their VP1 gene sequences. In this study, 33 EV71 strains obtained from GenBank were used as reference genotypes (Table S1 in File S1).
The 508-nucleotide of VP1 partial sequence (positions 2643–3150, relative to strain EV71/BrCr) of the 124 EV71 isolates (Table S2 in File S1) were determined and subjected to phylogenetic analyses (Figure 6). Results revealed that the VP1 sequences of all EV71 isolates were clustered with sequences of the EV71 C4 sub-genotype (Figure 6), which has been the dominant circulating EV71 sub-genotype in China since 1998 (It has been reported that subgenotype C4 of EV71 has been the sole viral genetic lineage circulating in mainland China since 1998 [25], [26], [59], [101]. It has been reported that the large HFMD outbreaks with fatal neurological complications that have occurred were mainly due to subgenotype C4a of EV71 [26], [58], [59]. In this study, further phylogenetic analysis showed that 56 EV71 strains and 68 EV71 strains belonged to the C4a and C4b clusters, respectively (Figure 6). EV71 strains isolated from patients in Wuhan, Ezhou, Hanchuan, Xiantao, and Xiaogan belonged to the C4a and C4b clusters, while the EV71 strains isolated from other areas belonged mainly to the C4b cluster (Figure 6). The 56 EV71 C4a strains were isolated from patients in Wuhan, Hanchuan, Xiaotao, and Xiaogan, while 68 EV71 C4b strains were isolated from patients in Wuhan, Shangcheng, Hanchuan, Ezhou, Xiantao, Macheng, Xiaogan, Tianmen, Xixian, Huangchuan, Qichun, and Tongshan (Figure 6). Notably, 9 EV71 C4b strains from Shangcheng, Xixian, and Huangchuan formed a distinct clad (Figure 6), indicating that the EV71 strains circulating in these regions were different from those circulating in Wuhan due to a unique transmission pathway.
Phylogenetic dendrogram constructed by the neighbor-joining method based on 508-bp partial VP1 sequence of the 124 EV71 strains isolated in this study and 38 reference strains. Strains indicated by a filled circle (•) and triangle (▴) are EV71 strains isolated from mild cases and severe cases, respectively, in a HFMD outbreak During April 2011 to March 2012. Bootstrap values with >70 replications are shown at the branch nodes as percentages. The scale bar represents the genetic distance. Strain CVA16 G-10 and CVA16 FY18 strain from China were used as out groups.
In addition, complete sequences of VP1 gene (891 nucleotides, positions 2446–3336, relative to strain CVA16/G10) from 42 different CVA16 isolates (Figure 7A, Table S3 in File S1) and partial sequences of VP3-VP1 region (209 nucleotides, positions 2335–2543, relative to strain CVA16/G10) of 38 different CVA16 isolates (Figure 7B, Table S4 in File S1) were determined. Phylogenetic analyses showed that all 80 CVA16 strains belonged to the B1 sub-genotype. It is known that B1 sub-genotype of CVA16 can be further classified into three clusters: B1a, B1b, and B1c. We revealed that 25 CVA16 strains belonged to B1a and 55 CVA16strains belonged to B1b. Our results were consistent with previous reports, which showed that almost all CVA16 strains isolated from China from 1999 to 2011 belonged to B1a and B1b clusters [31], [69]. We also showed that the 25 CVA16B1a strains were mainly identified from Wuhan, while the 55 CVA16B1b strains were isolated from Wuhan, Shangcheng, Ezhou, Hanchuan, Xiaogan, Macheng, and Guangshan, suggesting that B1b is more widespread than B1a.
(A) Phylogenetic dendrogram constructed by the neighbor-joining method based on 891-bp complete VP1 sequence of the 42 CVA16 strains isolated in this study. (B) Phylogenetic dendrogram constructed by the neighbor-joining method based on 209-bp partial VP3-VP1 sequence of the 38 CVA16 strains. No VP3-VP1 sequences from B1c and B2 reference strains were available from GenBank. Strains indicated by a filled circle (•) and triangle (▴) are CVA16strains isolated from mild cases and severe cases, respectively, during the HFMD outbreak. Bootstrap values with >70 replications are shown at the branch nodes as percentages. The scale bar represents the genetic distance. Strain enterovirus 71 BrCr and another enterovirus 71 Hubei-09 strain from China were used as out groups.
Genomic recombination between EV71 and CVA16 strains
An important property of enteroviruses is the ability to undergo extensive genetic recombination and viral polymerase-generated mutations, by which the viruses create genetic variation and evolution. Genomic recombination in enteroviruses was originally identified in poliovirus [74], [75]. Since then many studies have revealed that genomic recombination is a significant and relatively frequent event in circulating enteroviruses and that genetic exchanges could occur within a given serotype and between different serotypes [61], [76], [78], [79], [102]–[105].
In this study, phylogenetic analysis revealed that the sequences of three EV71 isolates (two from severe cases and one from mild case) not only shared 77.7%–78.1% identity in nucleotides and 92.0%–92.2% identity in amino acids with EV71 prototype strain BrCr, but also shared 84.6–85.0% homology in nucleotides and 97.4–97.6% homology in amino acids with the CVA16 prototype strain G-10. In addition, phylogenetic analysis also showed that the sequences of three CVA16 isolates (two from severe cases and one from mild case) not only shared 77.7%–78.1% identities in nucleotides and 92.0%–92.2% identities in amino acids with the EV71 prototype strain BrCr, but also shared 84.6–85.0% homology in nucleotides and 97.4–97.6% identity in amino acids with CVA16 prototype strain B1b. To identify the possible genomic recombination events within these strains, the entire genomic sequences of the three EV71 strains (Wuhan1117/HuB/CHN/2011, Wuhan1042/HuB/CHN/2011, Wuhan1143/HuB/CHN/2011) and the three CVA16 strains (Wuhan0109/HuB/CHN/2011, Wuhan0157/HuB/CHN/2011, and Wuhan0127/HuB/CHN/2011) were determined and submitted to GenBank (accession nos. JX986737, JX986738, JX986739, JX986740, JX986741, and JX986742), respectively.
Phylogenetic analyses revealed that the three EV71 strains (JX986737, JX986738, and JX986739) belonged to the C4a sub-genotype based on the sequences of VP1. The genome homology between the two EV71 strains (Wuhan1117/HuB/CHN/2011 and Wuhan1143/HuB/CHN/2011) isolated from the two severe cases was 99.7% for nucleotide and 99.6% for amino acid, respectively. The genome homology between the EV71 strain (Wuhan1117/HuB/CHN/2011) isolated from a severe case and the EV71 strain (Wuhan1143/HuB/CHN/2011) isolated from a mild case was 98.1% for nucleotide and 99.3% for amino acid, respectively. Similarity plot graphs (Figure 8A) and bootscan analyses (Figure 8B) based on entire genomic sequences demonstrated that the EV71 strain (Wuhan1042/HuB/CHN/2011, accession no. JX986737) isolated from a severe case had a very high sequence similarity (≥96%) to the EV71 C4a sub-genotype (Guangdong/GD/CHN/2009) in the structural (P1) region and 2A–2B (P2) region, while had a relatively high sequence similarity (≥90%) to the EV71 C4b sub-genotype (SHZH98/GD/CHN/1998) in the 2C (P2) and P3 regions. The most likely breakpoints were located between nucleotides 4034 and 4120, corresponding to the 2B–2C junctions, as determined using the method of maximization of χ2 (max χ2 = 122.4, p<0.001). Similar results were obtained when EV71 strain (Wuhan1117/HuB/CHN/2011, accession no. JX986738) from a severe case and EV71 strain (Wuhan1143/HuB/CHN/2011, accession no. JX986739) from a mild case were analyzed (data not shown). These results suggested that the three EV71 strains might be recombinant viruses with CVA16 in 2B–2C region.
(A) Similarity plot of EV71 strain Wuhan1042/HuB/CHN/2011 and its potential parent. The y-axis gives the percentage identity in a sliding 200-bp window with 20-bp steps. (B) Bootscan analyses of EV71 strain Wuhan1042/HuB/CHN/2011 and its potential parent. The y-axis gives the percentage of permutated trees in a sliding 200-bp window with 20-bp steps.
Phylogenetic analyses also revealed that the three CVA16 strains belonged to the B1b sub-genotype based on the sequences of VP1. The genome homologies between the two CVA16 strains (Wuhan0109/HuB/CHN/2011 and Wuhan1143/HuB/CHN/2011) from severe cases were 99.7% for nucleotide and 99.5% for amino acid, while the genome homologies between the CVA16 strain (Wuhan1117/HuB/CHN/2011) from a severe case and the CVA16 strain (Wuhan1143/HuB/CHN/2011) from a mild case were (96.2% for nucleotide and 99.0% for amino acid, respectively. Similarity plot graphs (Figure 9A) and bootscan analyses (Figure 9B) based on entire genomic sequences revealed that the CVA16 strain (Wuhan0109/HuB/CHN/2011, accession no. JX986740) from a severe case had a relatively high sequence similarity (≥76%) to the CVA16 A sub-genotype (FY18/AH/CHN/2008) in the structural (P1) and 2A–2B (P2) regions, but had a higher sequence similarity (≥82%) to the EV71 A sub-genotype (Hubei-09/HuB/CHN/2009 2C) in the P2, P3, and 3′UTR regions. The most likely breakpoints were located between nucleotides 3698 and 3734, corresponding to the 2A–2B junctions, as determined using the method of maximization of χ2 (max χ2 = 69.8, p<0.001). Similar results were obtained when CVA16 strain (Wuhan0157/HuB/CHN/2011, accession no. JX986741) from a severe case and CVA16 strain (Wuhan0127/HuB/CHN/2011, accession no. JX986742) from a mild case were analyzed (data not shown). These results suggested that the three CVA16 strains might be recombinant viruses with EV71 in 2A–2B region.
(A) Similarity plot of CVA16 strain Wuhan0109/HuB/CHN/2011 and its potential parent. The y-axis gives the percentage identity in a sliding 200-bp window with 20-bp steps. (B) Bootscan analyses of CVA16 strain Wuhan0109/HuB/CHN/2011 and its potential parent. The y-axis gives the percentage of permutated trees in a sliding 200-bp window with 20-bp steps.
Discussion
Since the first case was reported [2], HFMD has continued to spread globally and is a continuing threat to public health [3]–[10]. Regularly reoccurring outbreaks of HFMD have been relatively centralized in the Asia-Pacific region recently [12], [14], [18], [21], [23], [24]. Since 2008, epidemic outbreaks of HFMD in China have resulted in a total of approximately 3 million cases, including approximately 1500 fatal cases [25], [27]–[29], [32], [33].
In this study, we revealed that EV71 and CVA16 were the main causative agents in a large HFMD outbreak during April 2011 to March 2012 in Central China. This result is consistent with previous reports, which demonstrated that HFMD is most commonly caused by human enteroviruses, especially EV71 or CVA16 [34], [38]. More interestingly, we also demonstrated that EV71 and CVA16 were co-circulated in this HFMD outbreak. It has been reported that many large outbreaks of HFMD were only EV71-associated [8], [15], [16], [19], [25], [28], [44], [45], [47], [48], [52]–[54], [57]–[59], [89].
CVA16 related to HFMD have been endemic to Southeast Asia and the Pacific region for decades [21], [66]–[69]. Thus, co-circulation of EV71 and CVA16 during a large outbreak of HFMD in Central China should gain more attention as there may be an upward trend in co-circulation of the two pathogens globally.
We showed that HFMD incidences were observed throughout the study period from April 2011 to March 2012, suggesting that HFMD became endemic year-around in Central China. However, two distinct monthly peaks of HFMD cases were observed, the first one occurred in July and the second one in November. Distinct monthly distributions of EV71-infected and CVA16-infected cases were also observed in the two periods: EV71 was the main causative agent in July, while CVA16 was the predominant causative agent in November. This is the first time that CVA16, rather than EV71, was the main causative agent during an outbreak of HFMD in early winter in Mainland China since 2008. Ongoing surveillance is needed to confirm whether this alternating epidemic pattern of EV71- and CA16-associated HFMD will recur in a regular annual cycle in the future.
In addition, EV71-associated and CVA16-associated HFMD cases were reduced in January and February, possibly due to the cold climate during these months, but increased in March. The epidemic season (from May to July) of EV71-associated HFMD was significantly different from the epidemic season (from October to December) of CVA16-associated HFMD, suggesting that outbreaks of EV71 and CVA16 were seasonal dependent. Seasonality in the incidence of HFMD has been previously reported, including a seasonal peak of HFMD was detected during summer in Japan [12], [43] and a seasonal peak of HFMD was detected during autumn in Finland [87]. In Asian, HFMD epidemics usually peak in the late spring and early summer, along with a second small peak in late autumn and early winter [16], [20], [88], [89]. The seasonality of HFMD suggests that meteorological variables might be influential in the spread of the disease [43], [90]–[92].
HFMD is a common communicable disease that usually affects children aged below 10 years, especially those aged below 5 years [1], [11], [22]. In this study, we showed that the most HFMD patients were less than 5 years old and children of age 1–3-year-old were the major affected group. This group was unlikely in the kindergartens, but most likely stayed at different households, suggesting that kindergarten and childcare centers were not the major sites for dissemination of the disease. It has reported that EV71 transmission rates were high for children among household contacts, including siblings, cousins, parents, grandparents, uncles, and aunts, and EV71-infected adults in family were usually asymptomatic or mild [93]. The one-child policy was strictly enforced in Mainland China, and thus it is possible that adults with asymptomatic infection in the family may be the major infectious source of HFMD in children of 1–3-year-old. Notably, there was a reduced incidence of HFMD in children less than 1 year-old, presumably due to maternal antibodies and less exposure to other children. For children old than 3-year, the number of HFMD cases was decreased as age increased. Gender distribution analysis of HFMD showed that 66.3% were male and 33.6% were female. For the EV71 cases, the ratio of male to female was twice (2.0∶1.0), while for the CVA16 cases, the ratio of male cases to female cases was almost twice (1.7∶1.0), which was similar to previous report [57].
It has been confirmed that large HFMD outbreaks with fatal neurological complications that have occurred since 2008 in China were mainly due to subgenotype C4 of EV71 [26], [60]–[62]. Enterovirus infections are generally mild, however, they have been implicated to cause a variety of diseases, ranging from asymptomatic infection, herpangina, HFMD, to more severe diseases such as menigoencephalitis, myocarditis, and neonatal sepsis, and possibly fatal encephalitis [34], [42], [49]. We showed that fever, hyperglycemia, vomiting, limb shaking, lethargy, and convulsion were significantly more frequent detected in patients infected with EV71 compared to patients infected with CVA16. These results were in agreement with previous studies [21], [23], [106]–[108]. In contrast, the illness caused by CVA16 infection is usually mild [70]. We showed that upper respiratory tract infections were significantly more frequent in CVA16-infected patients compared to EV71-associated patients, but the percentages of patients with bronchitis, leukocytosis, polycythemia, and the concentrations of leukocytes, erythrocytes, and glucose were less than 10% for both EV71 and CVA16 infections. The mean serum concentrations of CRP were significantly higher in patients with CVA16 infection than that with EV71 infection. The higher levels of CRP with lower concentrations of leukocytes in CVA16-infected patients indicated that leukocyte activation, rather than leukocyte redistribution, may occur in patients with CVA16 infection. To some extent, it may explain why most cases of CVA16 infection were mild.
Phylogenetic analyses revealed that all 124 EV71 strains isolated in this study belong to C4 sub-genotype of EV71, which has been the dominant circulating EV71 sub-genotype in China since 1998 [26], [101]. Further phylogenetic analysis showed that 56 EV71 strains and 68 EV71 strains belong to the C4a and C4b clusters, respectively. Previous studies showed that EV71 C4b was the predominant strain from 1998–2004 in Mainland China, and since then EV71 C4a has been the predominant strain [25], [59], [109]. Thus, our results indicated that after a quiet period of approximately six years, EV71 C4b reemerged and caused a large-scale HFMD epidemic in Central China.
All previously characterized CVA16 strains were divided into two genotypes (A and B) and three sub-genotypes (A, B1, and B2) based on their VP1 gene sequences. We showed that all 80 CVA16 strains isolated in this study belonged to the B1 sub-genotype. It has been showed that almost all CVA16 strains isolated from 1999 to 2011 in China belonged to B1a and B1b clusters [31], [69]. Our results revealed that 25 CVA16 strains belonged to B1a and 55 CVA16strains belonged to B1b, indicating that CVA16 sub-genotype B1b was more widespread than B1a during this outbreak.
Phylogenetic analyses revealed that the sequences of three EV71 isolates (two from severe cases and one from mild case) not only share high homology with EV71, but also share high identity with CVA16. Similarly, the sequences of three CVA16 isolates (two from severe cases and one from mild case) not only share high identity with CVA16, but also share high homology with EV71. To identify the possible genomic recombination events within these isolates, the entire genomic sequences of the six strains were determined. Similarity plot graphs and bootscan analyses demonstrated that the three EV71 strains had a very high sequence similarity to EV71 C4a sub-genotype in the P1 and P2 regions, while had a relatively high sequence similarity to the EV71 C4b sub-genotype in the P2 and P3 regions. The most likely breakpoints were located between nucleotides 4034 and 4120, corresponding to the 2B–2C junctions, suggesting that the three EV71 strains were recombinant viruses with CVA16 in 2B–2C region. The three CVA16 strains had a relatively high sequence similarity to the CVA16 A sub-genotype in the P1 and P2 regions, but had a higher sequence similarity to the EV71 A sub-genotype in the P2, P3, and 3′UTR regions. The most likely breakpoints were located between nucleotides 3698 and 3734, corresponding to the 2A–2B junctions, suggesting that the three CVA16 strains were recombinant viruses with EV71 in 2A–2B region. These results suggested that the 2B–2C junction and 2A–2B junction in the non-structural region P2 are likely hot spots for enterovirus recombination.
Enteroviruses are able to undergo extensive genetic recombination, by which the viruses create genetic variation and evolution [74], [75]. Genomic recombination is a significant event in circulating enteroviruses and genetic exchanges could occur within a given serotype and between different serotypes [61], [76]–[79], [102]–[105].
In recent years, several types of EV71 vaccines have been developed to prevent HFMD [110]–[115]. The recombination of CVA16 and widespread epidemic caused by this strain indicates that CVA16 should be included along with EV71 to create a bivalent vaccine in order to provide broader, more effective protection against HFMD.
Thus, the comprehensive epidemiology and virology survey of an HFMD outbreak described in this paper would provide valuable information for improved child care and disease prevention. In addition, this founding would provide insight into developing public-health interventions for the control and prevention of HFMD, especially for reducing the risk of HFMD in high-risk individuals by taking precautions against enterovirus infections.
Materials and Methods
Ethics statement
The written informed consents from the parents or guardians of children or minors have been obtained. The study was conducted according to the principles of the Declaration of Helsinki and approved by the Institutional Review Board of the College of Life Sciences, Wuhan University, in accordance with its guidelines for the protection of human subjects.
Clinical information and specimen collection
Collection of clinical information and specimens was curried out as described previously [28]. Mild cases of HFMD were defined as patients with vesicular lesions on their palms, feet, and mouth, with or without fever, whereas severe cases were defined as HFMD accompanied by neurologic or cardiopulmonary complications [16]. All HFMD cases in this study were hospitalized at the Wuhan Medical Treatment Center (also Wuhan Infectious Diseases Hospital). Several cases had visited the smaller hospitals within their district area before being referred to the Wuhan Medical Treatment Center and some of them had already received antiviral therapy at the smaller hospitals. For each patient, a clinical survey was filled out and a thorough medical exam was administered to evaluate other HFMD-associated symptoms. These surveys were obtained from the hospital and used in this epidemiologic study. Medical practitioners collected throat swabs from each case when applicable. These samples were used in the lab for diagnosis and viral isolation.
Viral RNA extraction and reverse transcription
Viral RNA extraction and reverse transcription-PCR (RT-PCR) were performed as described previously [28]. Briefly, viral RNA was extracted from primary clinical specimens or infected cell culture supernatants using a High Pure Viral RNA Extraction Kit according to the manufacturer's instructions (Roche, Mannheim, Germany). Reverse transcription was performed using random hexamers and M-MLV reverse transcriptase (Promega, Madison, WI, USA).
Conventional RT-PCR and enterovirus sequence identification
Information about the primer pairs used for the detection, classification, and full-length genome sequencing are shown in Table 1. The primers used to detect EV71 and CVA16 were described previously [28]. First, pan-enterovirus primers (PE1 and PE2) were used to detect human enterovirus by amplifying a fragment within the 5′ untranslated region (5′UTR), which is highly conserved among all human enteroviruses. The primers EV71-S and EV71-A were used for the detection of EV71, while the primers CA16-S and CA16-A were used for the detection of CVA16. All samples were subjected to PCR using each of the three sets of primers. For the typing and genomic sequencing of the isolates, several primer sets (Table 1) were used. The 5′ and 3′ termini of the viral genome were determined using 5′ and 3′ RACE according to the manufacturer's instructions (Life Technologies, Grand Island, NY). The PCR products were purified using a gel extraction kit (Omega Bio-Tek Inc., Norcross, GA), and cloned into pMD-18T (Takara, Dalian, China). Positive clones were subjected to bi-directional DNA sequencing (Life Technologies).
Enterovirus isolation
To isolate viruses from the clinical specimens, human rhabdomyosarcoma (ATCC CCL-136), human laryngeal epithelial (ATCC CCL-23), and African green monkey kidney (ATCC CCL-81) cells were grown in Dulbecco's modified Eagle's medium (DMED) (Life Technologies) containing 10% fetal bovine serum (FBS) (Life Technologies). The specimens were concentrated at 6000 × g for 5 min, and then 50–100 µl of each concentrates was inoculated into a 25-cm2 flask containing confluent cell monolayers. After virus absorption for 2 h at 37°C, 4 ml of DMEM supplemented with 2% heat-inactivated FBS was added to each flask, and the flasks were incubated for 5–7 days at 37°C with 5% CO2. Characteristic enterovirus cytopathic effects (CPE) were evaluated microscopically each day, the isolates were harvested when 75% of the cultures showed CPE. The presence of enterovirus in the harvests was confirmed by RT-PCR using human enterovirus-specific primers.
Phylogenetic analyses
Sequences of EV71 or CVA16 were aligned with reference sequences using the Clustal W program implemented in MEGA5.05 [116]. The reference sequences represented all known EV71 and CVA16 sub-genotypes were obtained from the GenBank database (Table S1). Phylogenetic dendrograms were constructed using the neighbor-joining method with MEGA5.05. The stability of the nodes was tested using the bootstrap method with a bootstrap value of 1000 replicates. Bootstrap values below 70% were hidden.
Similarity plots and bootscan analyses
Similarity plots and bootscan analyses of the complete genome alignments were performed using the SimPlot software package version 3.5.1 [116]–[118]. Similarity was calculated in each 200-nucleotide window using the Kimura two-parameter distance method with a transition-transversion ratio of 2. The window was advanced successively along the genome alignment in 20-nucleotide increments. The breakpoints were identified using the method of maximization of χ2 [119], which was calculated with SimPlot software.
Data analyses
All statistical analyses were performed using Microsoft Excel 2010 (Microsoft, Redmond, WA) or SPSS software version 13.0 (SPSS Institute, Cary, NC). Differences in proportions and means were evaluated using Fisher's exact test and Student's t-test, respectively. A p-value <0.05 was considered statistically significant. Geo-statistical maps were used to characterize the spatial distribution with ArcInfo software version 9.3 (ESRI, Redlands, CA).
Author Contributions
Conceived and designed the experiments: YL JW. Performed the experiments: WL YX TL ZW MY KQ. Analyzed the data: WL SW YL JW. Contributed reagents/materials/analysis tools: WL SW YL JW. Wrote the paper: WL YL JW. Obtained clinical samples: WL SW ZW KQ. Sequence analysis: WL.
References
- 1.
World Health Organization (2011) A guide to clinical management and public health response for Hand, Foot and Mouth disease (HFMD). Geneva: WHO Press.
- 2. Robinson CR, Doane FW, Rhodes AJ (1958) Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Assoc J 79: 615–621.
- 3. Ishimaru Y, Nakano S, Yamaoka K, Takami S (1980) Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child 55: 583–588.
- 4. Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, et al. (1988) Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 7: 484–488.
- 5. Alexander JP Jr, Baden L, Pallansch MA, Anderson LJ (1994) Enterovirus 71 infections and neurologic disease—United States, 1977–1991. J Infect Dis 169: 905–908.
- 6. Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, et al. (2002) Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 46: 621–627.
- 7. Bible JM, Iturriza-Gomara M, Megson B, Brown D, Pantelidis P, et al. (2008) Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol 46: 3192–3200.
- 8. Qiu J (2008) Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7: 868–869.
- 9. Bracho MA, Gonzalez-Candelas F, Valero A, Cordoba J, Salazar A (2011) Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008. Emerg Infect Dis 17: 2223–2231.
- 10. Gopalkrishna V, Patil PR, Patil GP, Chitambar SD (2012) Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol 61: 420–425.
- 11. Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, et al. (2009) Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 62: 254–259.
- 12. Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, et al. (2012) Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis 18: 337–339.
- 13. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, et al. (2000) Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31: 678–683.
- 14. Chua KB, Chua BH, Lee CS, Chem YK, Ismail N, et al. (2007) Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malays J Pathol 29: 69–78.
- 15. Ooi MH, Wong SC, Podin Y, Akin W, del Sel S, et al. (2007) Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis 44: 646–656.
- 16. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, et al. (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341: 929–935.
- 17. Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT (2007) An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 77: 188–191.
- 18. Wei SH, Huang YP, Liu MC, Tsou TP, Lin HC, et al. (2011) An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis 11: 346.
- 19. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, et al. (2003) Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9: 78–85.
- 20. Ang LW, Koh BK, Chan KP, Chua LT, James L, et al. (2009) Epidemiology and control of hand, foot and mouth disease in Singapore, 2001–2007. Ann Acad Med Singapore 38: 106–112.
- 21. Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, et al. (2010) The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 14: e1076–1081.
- 22. Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, et al. (2010) Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008–2009. Jpn J Infect Dis 63: 229–233.
- 23. Ryu WS, Kang B, Hong J, Hwang S, Kim J, et al. (2010) Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J Clin Microbiol 48: 2490–2494.
- 24. Ma E, Chan KC, Cheng P, Wong C, Chuang SK (2010) The enterovirus 71 epidemic in 2008—public health implications for Hong Kong. Int J Infect Dis 14: e775–780.
- 25. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351–2352.
- 26. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, et al. (2009) An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 44: 262–267.
- 27. Mao LX, Wu B, Bao WX, Han FA, Xu L, et al. (2010) Epidemiology of hand, foot, and mouth disease and genotype characterization of Enterovirus 71 in Jiangsu, China. J Clin Virol 49: 100–104.
- 28. Liu MY, Liu W, Luo J, Liu Y, Zhu Y, et al. (2011) Characterization of an outbreak of hand, foot, and mouth disease in Nanchang, China in 2010. PLoS One 6: e25287.
- 29. Yang F, Zhang T, Hu Y, Wang X, Du J, et al. (2011) Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J 8: 508.
- 30. De W, Changwen K, Wei L, Monagin C, Jin Y, et al. (2011) A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch Virol 156: 945–953.
- 31. Ni H, Yi B, Yin J, Fang T, He T, et al. (2012) Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008–2011. J Clin Virol 54: 342–348.
- 32. Zeng M, Li YF, Wang XH, Lu GP, Shen HG, et al. (2012) Epidemiology of hand, foot, and mouth disease in children in Shanghai 2007–2010. Epidemiol Infect 140: 1122–1130.
- 33. Liu Y, Wang X, Sun D, Ding S, Zhang B, et al. (2013) Detecting Spatial-Temporal Clusters of HFMD from 2007 to 2011 in Shandong Province, China. PLoS One 8: e63447.
- 34.
Kliegman R, Nelson WE (2011) Nelson textbook of pediatrics, 19th ed. Philadelphia, PA: Elsevier/Saunders. p. 242.
- 35.
Stanway G, Brown F, Christian P, Hovi T, Hyypia T, et al. (2005) In: Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press. 757–778.
- 36.
Racaniello VR (2007) Picornaviridae: the viruses and their replication. In Knipe D. M., et al., editors. (ed.), Fields Virology, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins. p. 796–839.
- 37.
Pallansch M, Roos R (2007) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Knipe D. M., et al., editors. (ed.), Fields Virology, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins. p. 839–893.
- 38.
Mandell GL, Bennett JE, Dolin R (2010) Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. p.172.
- 39. Schmidt NJ, Lennette EH, Ho HH (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129: 304–309.
- 40. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, et al. (1974) Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet 2: 112.
- 41. Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, et al. (1979) Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 60: 329–340.
- 42. Hagiwara A, Yoneyama T, Takami S, Hashimoto I (1984) Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease. Arch Virol 79: 273–283.
- 43. Onozuka D, Hashizume M (2011) The influence of temperature and humidity on the incidence of hand, foot, and mouth disease in Japan. Sci Total Environ 410–411: 119–125.
- 44. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY (1998) Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 352: 1391.
- 45. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, et al. (1999) Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354: 1682–1686.
- 46. AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, et al. (1999) Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res 61: 1–9.
- 47. Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H (1999) Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol 20: 17–23.
- 48. McMinn P, Stratov I, Nagarajan L, Davis S (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32: 236–242.
- 49. McMinn PC (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91–107.
- 50. Shekhar K, Lye MS, Norlijah O, Ong F, Looi LM, et al. (2005) Deaths in children during an outbreak of hand, foot and mouth disease in Peninsular Malaysia—clinical and pathological characteristics. Med J Malaysia 60: 297–304.
- 51. Hosoya M, Kawasaki Y, Sato M, Honzumi K, Kato A, et al. (2006) Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr Infect Dis J 25: 691–694.
- 52. Schuffenecker I, Mirand A, Antona D, Henquell C, Chomel JJ, et al. (2011) Epidemiology of human enterovirus 71 infections in France, 2000–2009. J Clin Virol 50: 50–56.
- 53. Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, et al. (2009) Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J 28: 904–910.
- 54. Wong SS, Yip CC, Lau SK, Yuen KY (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138: 1071–1089.
- 55. Kim KH (2010) Enterovirus 71 infection: An experience in Korea, 2009. Korean J Pediatr 53: 616–622.
- 56. Lan YC, Lin TH, Tsai JD, Yang YC, Peng CT, et al. (2011) Molecular epidemiology of the 2005 enterovirus 71 outbreak in central Taiwan. Scand J Infect Dis 43: 354–359.
- 57. Tian H, Yang QZ, Liang J, Dong SY, Liu ZJ, et al. (2012) Clinical features and management outcomes of severe hand, foot and mouth disease. Med Princ Pract 21: 355–359.
- 58. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, et al. (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7: 94.
- 59. Tan X, Huang X, Zhu S, Chen H, Yu Q, et al. (2011) The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6: e25662.
- 60. Wang X, Zhu C, Bao W, Zhao K, Niu J, et al. (2012) Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One 7: e32405.
- 61. Zhang Y, Tan X, Cui A, Mao N, Xu S, et al. (2013) Complete genome analysis of the C4 subgenotype strains of enterovirus 71: predominant recombination C4 viruses persistently circulating in China for 14 years. PLoS One 8: e56341.
- 62. Wen HL, Si LY, Yuan XJ, Hao SB, Gao F, et al. (2013) Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes. Virol J 10: 115.
- 63. Sickles GM, Mutterer M, Feorino P, Plager H (1955) Recently classified types of Coxsackie virus, group A; behavior in tissue culture. Proc Soc Exp Biol Med 90: 529–531.
- 64. Poyry T, Hyypia T, Horsnell C, Kinnunen L, Hovi T, et al. (1994) Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology 202: 982–987.
- 65. Doraisingham S, Goh KT, Ling AE (1987) Epidemiology of viral infections in Singapore. Ann Acad Med Singapore 16: 243–249.
- 66. Yan JJ, Su IJ, Chen PF, Liu CC, Yu CK, et al. (2001) Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol 65: 331–339.
- 67. Li L, He Y, Yang H, Zhu J, Xu X, et al. (2005) Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 43: 3835–3839.
- 68. Tu PV, Thao NT, Perera D, Huu TK, Tien NT, et al. (2007) Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis 13: 1733–1741.
- 69. Zhang Y, Wang D, Yan D, Zhu S, Liu J, et al. (2010) Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol 48: 619–622.
- 70. Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, et al. (1999) Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 18: 1092–1096.
- 71. Wright HT Jr, Landing BH, Lennette EH, Mc AR (1963) Fatal infection in an infant associated with Coxsackie virus group A, type 16. N Engl J Med 268: 1041–1044.
- 72. Goldberg MF, Mc AA (1963) Myocarditis possibly due to Coxsackie group A, type 16, virus. J Pediatr 62: 762–765.
- 73. Wang CY, Li Lu F, Wu MH, Lee CY, Huang LM (2004) Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 23: 275–276.
- 74. Hirst GK (1962) Genetic recombination with Newcastle disease virus, polioviruses, and influenza. Cold Spring Harb Symp Quant Biol 27: 303–309.
- 75. Ledinko N (1963) Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20: 107–119.
- 76. Oberste MS, Maher K, Pallansch MA (2004) Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol 78: 855–867.
- 77. Simmonds P, Welch J (2006) Frequency and dynamics of recombination within different species of human enteroviruses. J Virol 80: 483–493.
- 78. Yozwiak NL, Skewes-Cox P, Gordon A, Saborio S, Kuan G, et al. (2010) Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol 84: 9047–9058.
- 79. Hu YF, Yang F, Du J, Dong J, Zhang T, et al. (2011) Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A. . J Clin Microbiol 49: 2426–2434.
- 80. Kapusinszky B, Szomor KN, Farkas A, Takacs M, Berencsi G (2010) Detection of non-polio enteroviruses in Hungary 2000–2008 and molecular epidemiology of enterovirus 71, coxsackievirus A16, and echovirus 30. Virus Genes 40: 163–173.
- 81. Rabenau HF, Richter M, Doerr HW (2010) Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol 199: 45–51.
- 82. Yip CC, Lau SK, Zhou B, Zhang MX, Tsoi HW, et al. (2010) Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch Virol 155: 1413–1424.
- 83. Yan XF, Gao S, Xia JF, Ye R, Yu H, et al. (2012) Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis 44: 297–305.
- 84. Chan YF, AbuBaker S (2004) Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg Infect Dis 10: 1468–1470.
- 85. Yoke-Fun C, AbuBakar S (2006) Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol 6: 74.
- 86. Huang SC, Hsu YW, Wang HC, Huang SW, Kiang D, et al. (2008) Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res 131: 250–259.
- 87. Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen ML, et al. (2010) Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol 48: 49–54.
- 88. Ma E, Lam T, Chan KC, Wong C, Chuang SK (2010) Changing epidemiology of hand, foot, and mouth disease in Hong Kong, 2001–2009. Jpn J Infect Dis 63: 422–426.
- 89. Zhu Q, Hao Y, Ma J, Yu S, Wang Y (2011) Surveillance of hand, foot, and mouth disease in mainland China (2008–2009). Biomed Environ Sci 24: 349–356.
- 90. Hii YL, Rocklov J, Ng N (2011) Short term effects of weather on hand, foot and mouth disease. PLoS One 6: e16796.
- 91. Ma E, Lam T, Wong C, Chuang SK (2010) Is hand, foot and mouth disease associated with meteorological parameters? Epidemiol Infect 138: 1779–1788.
- 92. Urashima M, Shindo N, Okabe N (2003) Seasonal models of herpangina and hand-foot-mouth disease to simulate annual fluctuations in urban warming in Tokyo. Jpn J Infect Dis 56: 48–53.
- 93. Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, et al. (2004) Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291: 222–227.
- 94. Ku Z, Shi J, Liu Q, Huang Z (2012) Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71. J Virol Methods 186: 193–197.
- 95. Liu LJ, Xu HM, Li XJ, Wang J, Wang XJ, et al. (2012) Co-detection in the pathogenesis of severe hand-foot-mouth disease. Arch Virol 157: 2219–2222.
- 96. Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, et al. (2012) Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 7: e37206.
- 97. Ji BY, Guo Y, Guo Q (2011) Analysis of notifiable infectious disease surveillance and reporting of medical units in 6 provinces. Mod Preventive Med 13: 4226–4271.
- 98. Deshpande JM NS, Francis PP (2003) Enterovirus 71 isolated from a case of acute flaccid paralysis in India represents a new genotype. Curr Sci 84: 1350–1353.
- 99. Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, et al. (2004) Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 46: 231–235.
- 100. Huang YP, Lin TL, Kuo CY, Lin MW, Yao CY, et al. (2008) The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res 137: 206–212.
- 101. Guan D, van der Sanden S, Zeng H, Li W, Zheng H, et al. (2012) Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998–2010. PLoS One 7: e44386.
- 102. Santti J, Hyypia T, Kinnunen L, Salminen M (1999) Evidence of recombination among enteroviruses. J Virol 73: 8741–8749.
- 103. Lukashev AN, Lashkevich VA, Ivanova OE, Koroleva GA, Hinkkanen AE, et al. (2005) Recombination in circulating Human enterovirus B: independent evolution of structural and non-structural genome regions. J Gen Virol 86: 3281–3290.
- 104. Yip CC, Lau SK, Woo PC, Chan KH, Yuen KY (2011) Complete genome sequence of a coxsackievirus A22 strain in Hong Kong reveals a natural intratypic recombination event. J Virol 85: 12098–12099.
- 105. Han JF, Jiang T, Fan XL, Yang LM, Yu M, et al. (2012) Recombination of human coxsackievirus B5 in hand, foot, and mouth disease patients, China. Emerg Infect Dis 18: 351–353.
- 106. Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, et al. (1999) Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29: 184–190.
- 107. Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, et al. (2007) Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 356: 1226–1234.
- 108. Chen SP, Huang YC, Li WC, Chiu CH, Huang CG, et al. (2010) Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children's hospital experience. J Microbiol Immunol Infect 43: 99–104.
- 109. Zhang Y, Wang J, Guo W, Wang H, Zhu S, et al. (2011) Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China. PLoS One 6: e27895.
- 110. Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, et al. (2008) Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 26: 2882–2889.
- 111. Ong KC, Devi S, Cardosa MJ, Wong KT (2010) Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 84: 661–665.
- 112.
Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, et al. (2013) Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 9..
- 113. Zhu FC, Meng FY, Li JX, Li XL, Mao QY, et al. (2013) Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381: 2024–2032.
- 114.
Zhou XB, Lu JJ, Jiang YS, Huo Y, Wang JF, et al. (2013) A safety study of inactivated Enterovirus 71 vaccine. Hum Vaccin Immunother 9..
- 115. Liu L, Zhang Y, Wang J, Zhao H, Jiang L, et al. (2013) Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One 8: e54451.
- 116. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739.
- 117. Salminen MO, Carr JK, Burke DS, McCutchan FE (1995) Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11: 1423–1425.
- 118. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152–160.
- 119. Pond SLK, Posada D, Gravenor MB, Woelk CH, Frost SDW (2006) Automated phylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol 23: 1891–1901.